BioCentury
ARTICLE | Clinical News

Elobixibat regulatory update

February 8, 2017 10:46 PM UTC

Eisai’s EA Pharma Co. Ltd. subsidiary submitted an NDA in Japan for elobixibat to treat chronic constipation. EA has exclusive rights to elobixibat for gastrointestinal disorders in Japan and other As...